1. Neoadjuvant immunotherapy with combined ipilimumab and nivolumab in patients with melanoma with primary or in transit disease. (1st September 2020) Authors: Weber, J.; Glutsch, V.; Geissinger, E.; Haug, L.; Lock, J.F.; Schneider, F.; Kneitz, H.; Goebeler, M.; Schilling, B.; Gesierich, A. Journal: British journal of dermatology Issue: Volume 183:Number 3(2020) Page Start: 559 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗